Pfizer ends research for Alzheimer's, Parkinson's drugs

The drug company - which makes the lucrative drug, Viagra - said it was ending its neuroscience research to focus on areas where it was strongest.

by

    Alzheimer's and Parkinson's sufferers have been dealt a blow, with drug maker Pfizer deciding to end its research into the debilitating diseases.

    Many sufferers and their families had felt new hope when the pharmaceutical giant began early-stage research, but the company has now decided to invest elsewhere.

    Al Jazeera's John Hendren reports.


    YOU MIGHT ALSO LIKE

    Why some African Americans are moving to Africa

    Escaping systemic racism: Why I quit New York for Accra

    African-Americans are returning to the lands of their ancestors as life becomes precarious and dangerous in the USA.

    What happens when the US government shuts down?

    The US government has shut down. What happens next?

    US federal government begins partial shutdown after Senate blocks short-term spending bill. What happens next?

    Why is the West praising Malala, but ignoring Ahed?

    Why is the West praising Malala, but ignoring Ahed?

    Is an empowered Palestinian girl not worthy of Western feminist admiration?